Skip to main content
David Duncan, MD, Neurology, Neptune, NJ

David B Duncan MD

Neuroimmunology/Multiple Sclerosis


Director Jersey Shore University Medical Center MS Center

Join to View Full Profile
  • 1945 Route 33Neptune, NJ 07753

  • Phone+1 732-897-3620

  • Fax+1 732-897-3619

Dr. Duncan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Nuclear Medicine, 1993 - 1995
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineResidency, Neurology, 1988 - 1992
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1995 - 2027
  • NJ State Medical License
    NJ State Medical License 2012 - 2025
  • PA State Medical License
    PA State Medical License 1994 - 1998
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2014-2024
  • Westchester Magazine: Top Doctors Castle Connolly, 2011, 2013
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2012

Press Mentions

  • Twin Study Reveals Signs of MS That Might Be Detectable Before Symptoms
    Twin Study Reveals Signs of MS That Might Be Detectable Before SymptomsOctober 20th, 2024
  • Breakthrough Drug Offers Multiple Sclerosis Patients A Second Chance
    Breakthrough Drug Offers Multiple Sclerosis Patients A Second ChanceJune 14th, 2018
  • FDA Approves the First Biosimilar Drug to Treat Multiple Sclerosis
    FDA Approves the First Biosimilar Drug to Treat Multiple SclerosisAugust 30th, 2023
  • Join now to see all

Other Languages

  • German

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: